Fenofibric Acid (Alembic Pharmaceuticals Limited)


Welcome to the PulseAid listing for the Fenofibric Acid drug offered from Alembic Pharmaceuticals Limited. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alembic Pharmaceuticals Limited
NON-PROPRIETARY NAME: Fenofibric Acid
SUBSTANCE NAME: FENOFIBRIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Peroxisome Proliferator Receptor alpha Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-05-15
END MARKETING DATE: 0000-00-00


Fenofibric Acid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFenofibric Acid from Alembic Pharmaceuticals Limited
LABELER NAME: Alembic Pharmaceuticals Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 45(mg/1)
START MARKETING DATE: 2017-05-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 46708-244_c880d43a-fa8c-4f7a-a488-419bae7cc311
PRODUCT NDC: 46708-244
APPLICATION NUMBER: ANDA208705

Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Trilipix
Actavis Pharma, Inc.fenofibric acid
Alembic Pharmaceuticals Inc.Fenofibric Acid
Alembic Pharmaceuticals LimitedFenofibric Acid
AR Scientific, Inc.FIBRICOR
Aralez Pharmaceuticals US Inc.FIBRICOR
Caraco Pharma, Inc.FIBRICOR
Halton LaboratoriesFenofibric Acid
Impax GenericsFenofibric Acid
Mutual Pharmaceutical Company, Inc.Fenofibric Acid
Mylan Pharmaceuticals Inc.Fenofibric Acid
Physicians Total Care, Inc.Trilipix
Tribute Pharmaceuticals US, Inc.FIBRICOR
Zydus Pharmaceuticals USA IncFenofibric Acid